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Background: Recent research has yielded a wealth of data underscoring the key role of the cancer
microenvironment, especially immune and stromal cells, in the progression of cancer and the development of
metastases. However, the role of adjacent benign epithelial cells, which provide initial cell-cell contacts with cancer
cells, in tumor progression has not been thoroughly examined. In this report we addressed the question whether
benign MECs alter the transformed phenotype of human breast cancer cells.
Methods: We used both in vitro and in vivo co-cultivation approaches, whereby we mixed GFP-tagged MCF-10A
cells (G2B-10A), as a model of benign mammary epithelial cells (MECs), and RFP-tagged MDA-MB-231-TIAS cells
(R2-T1AS), as a model of breast cancer cells.
Results: The in vitro studies showed that G2B-10A cells increase the colony formation of R2-T1AS cells in both soft
agar and clonogenicity assays. Conditioned media derived from G2B-10A cells enhanced colony formation of
R2-T1AS cells, whereas prior paraformaldehyde (PFA) fixation of G2B-10A cells abrogated this enhancement effect.
Moreover, two other models of benign MECs, MCF-12A and HuMECs, also enhanced R2-T1AS colony growth in soft
agar and clonogenicity assays. These data reveal that factors secreted by benign MECs are responsible for the
observed enhancement of the R2-T1AS transformed phenotype. To determine whether G2B-10A cells enhance the
tumorigenic growth of co-injected R2-T1AS cells in vivo, we used the nude mouse xenograft assay. Co-injecting
R2-T1AS cells with G2B-10A cells ± PFA-fixation, revealed that G2B-10A cells promoted a ~3-fold increase in tumor
growth, irrespective of PFA pre-treatment. These results indicate that soluble factors secreted by G2B-10A cells play
a less important role in promoting R2-T1AS tumorigenesis in vivo, and that additional components are operative in
the nude mouse xenograft assay. Finally, using array analysis, we found that both live and PFA-fixed G2B-10A cells
induced R2-T1AS cells to secrete specific cytokines (IL-6 and GM-CSF), suggesting that cell-cell contact activates
R2-T1AS cells.
Conclusions: Taken together, these data shift our understanding of adjacent benign epithelial cells in the cancer
process, from passive, noncontributory cells to an active and tumor-promoting vicinal cell population that may
have significant effects early, when benign cells outnumber malignant cells.
Background
In recent years it has become increasingly clear that the
interactions between neoplastic cells and their tissue
microenvironment have a profound role in the progress
of cancer. Strong support for this concept comes from
epidemiologic studies, which have linked several
inflammatory conditions with an increased risk of cancer
[1-3]. Furthermore, pregnancy-associated breast cancer
diagnosed in the post-partum period is characterized by
a high incidence of metastases, which have been pro-
posed to be due to the pro-inflammatory changes in the
mammary gland that occur during involution [4-6].
Thus, both pathologic and physiologic inflammatory con-
ditions appear to contribute to tumor pathology by creat-
ing a microenvironment conducive to the progression
and spread of cancer. In addition to epidemiological data,
* Correspondence: a.gutierrez-hartmann@ucdenver.edu
1Molecular Biology Program, University of Colorado Denver, Aurora, CO
80045, USA
Poczobutt et al. BMC Cancer 2010, 10:373
http://www.biomedcentral.com/1471-2407/10/373
© 2010 Poczobutt et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.the important role of the microenvironment in cancer
has been underscored by multiple in vitro and in vivo
studies. For example, it has been well documented that
most primary and metastatic tumors are infiltrated by
immune cells that produce cytokines, cytotoxic media-
tors, interleukins, interferons, proteases, growth factors,
and angiogenic and lymphangiogenic factors, all of which
can be co-opted by neoplastic cells to contribute to the
progression of cancer and development of metastases
[1,2,7]. A large body of evidence exists documenting the
supporting role of stromal cells in the progression of can-
cer. In vivo studies, which used co-injections of cancer
cells with activated stromal cells in nude mouse xeno-
grafts, transgenic mouse model with fibroblast-specific
knock-out of TRIIb (TGF receptor IIb), or irradiation of
murine mammary fat pad, have consistently demon-
strated that activated stromal cells have a profound
enhancing effect on the growth of tumors, progression to
am o r ea g g r e s s i v ep h e n o t y p e, and formation of metas-
tases [8-14]. These studies also led to identification of
SDF-1 and CCL5 as the cytokines mediating the interac-
tions between stromal cells and breast cancer cells
[11,14]. In vitro studies have similarly shown that stromal
cells were able to induce growth-factor expression, as
well as promote proliferation and invasion of cancer cells
[12,14,15]. While an abnormal microenvironment can
promote the tumorigenic process, the normal microen-
vironment may be able to suppress it, as has been
demonstrated by normal myoepithelial cells inhibiting
the growth and progression of breast carcinoma cells in a
nude mouse xenograft [10]. Furthermore, the oncogenic
potential of transformed cells can be suppressed by a
normal embryonic environment [16-18].
As illustrated by the examples above, the main
research efforts have concentrated on delineating the
interactions between cancer cells and their surrounding
stroma. However, cancer cells may also interact with the
vicinal normal epithelial cells or with non-neoplastic
epithelial cells that have acquired some mutations but
have remained benign. While in advanced tumors non-
neoplastic epithelial cells may comprise a minute frac-
tion of the tumor microenvironment, in small, early
lesions, such as ductal carcinoma in situ of the breast,
the ratio of normal or benign epithelial cells to cancer
cells may favor the interaction with these epithelial cells
as critical determinants of cancer cell fate. Indeed, direct
contacts between microscopic malignant lesions and
normal appearing epithelial cells have been observed in
breast and in prostate tissues, however the biological
effects of these interactions are unknown [19,20]. Such
interactions may determine whether cancer cells
undergo apoptosis, become quiescent, or advance to
clinically-relevant tumors. Thus, the various modes by
which the non-neoplastic mammary epithelial cells may
control the fate of early neoplastic lesions provide
important considerations for strategies for cancer treat-
ment and chemoprevention. Despite their potential
importance, the interactions between normal or benign
epithelial cells and cancer cells have not been examined
in detail. The few published in vitro studies have used
various models of normal mammary epithelial cells to
demonstrate both inhibitory effects of normal epithelial
cells on cancer cells, such as inhibition of breast cancer
cell proliferation, and stimulatory effects, such as
enhancement of breast cancer cell invasion, with the lat-
ter being dependent on SDF-1 [21-26]. However, the
precise mechanism by which normal or benign epithelial
cells influence the transformed phenotype of cancer
cells is not known.
In this study, we used both in vitro and in vivo
approaches to address the hypothesis that benign mam-
mary epithelial cells influence the transformed pheno-
type of breast cancer cells. Our data show that soluble
factors secreted by benign mammary epithelial cells sti-
mulate formation of colonies in soft agar by breast can-
cer cells and increase their clonogenic growth in tissue
culture. We also show that G2B-10A benign mammary
epithelial cells stimulate the tumorigenic growth of R2-
T1AS cells in the nude mouse xenograft assay, however,
this effects is not dependent on factors secreted by the
benign cells, but rather may be the result of cell-cell
interactions.
Methods
Cell lines and cell culture
MCF-10A and MCF-12A cell lines were obtained from
American Type Culture Collection. G2B-10A and G-12A
cell lines were generated from MCF-10A and MCF-12A
cells, respectively, by infection with a GFP-expressing
lentivirus, as described below. G2B-10A and G-12A cells
were maintained in DMEM/F-12 medium (Invitrogen,
#11330) supplemented with 10 μg/ml insulin (Sigma,
#I5500), 0.5 μg/ml hydrocortisone (Sigma, #H0888), 100
ng/ml cholera toxin (Sigma, #C8052), 20 ng/ml EGF (epi-
dermal growth factor receptor, Invitrogen, #53003-018),
and 5% horse serum (Invitrogen, #16050-122). Cells were
passaged with trypsin twice a week. HuMEC cells (a kind
gift from Dr. DeGregori, University of Colorado) are
human mammary epithelial cells immortalized with
telomerase. HuMEC cells were maintained in HuMEC
basal serum-free medium (Invitrogen, # 12753018)
supplemented with HuMEC supplement kit (Invitrogen,
# 12755013), and passaged with trypsin three times a
week, according to the media manufacturer’sp r o t o c o l .
MDA-MB-231-T1AS cells are a variant of MDA-MB-231
selected for high tumorigenicity in mice [27]. The
red-marked R2-T1AS cells were generated from MDA-
MB-231-T1AS cells by infection with DsRed2-expressing
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cultured in high-glucose DMEM medium (Invitrogen,
#11965) supplemented with 15% horse serum (Invitro-
gen, #16050-122), 2.5% fetal bovine serum (FBS, Invitro-
gen, #16000-044), and non-essential amino-acids
(Invitrogen, #11140-050). Cells were passaged with tryp-
sin three times a week.
Lentivirus production and infection of target cells
The lentiviral vectors FUW (empty vector) and FUGW
(GFP-expressing) [28] were kindly provided by
Dr. DeGregori. To generate FURW (DsRed2-expressing)
lentivirus we subcloned the cDNA encoding DsRed2 red
fluorescent protein into FUW lentiviral backbone. To
this end, we digested pDsRed2-N1 plasmid (Clontech,
kindly provided by Dr. Verkhusha, University of Color-
ado Denver) with BamHI and MfeI restriction enzymes
a n di n s e r t e dt h er e s u l t i n g 800 bp fragment into FUW
vector, which was digested with BamHI and EcoRI.
Virus-containing supernatant was generated by Effec-
tene-mediated (Qiagen, #301425) co-transfection of
293T fibroblasts with the following plasmids: (1) FUGW
or FURW viral gene-transfer vector, (2) Delta8.9, the
HIV-1 packaging plasmid, expressing gag-pol and acces-
sory proteins, and (3) pCMV-VSVg, the envelope glyco-
protein plasmid. Virus-containing supernatant was
collected 48 and 72 h post-transfection, filtered through
0.45 μm syringe filter and stored at -80°C. To infect
cells, the virus-containing supernatant was diluted in
growth medium 1:3, supplemented with polybrene
(8 μg/ml), and overlaid on the target cells. After over-
night incubation with the viral supernatant, medium
was changed to fresh culture medium. Expression of
EGPF or DsRed2 was detectable by fluorescence micro-
scopy after 48-72 h post infection.
Paraformaldehyde (PFA) fixation of G2B-10A cells
G2B-10A cells were harvested with trypsin, and resus-
pended in culture medium. An equal volume of 4% PFA
solution was added to the cell suspension, resulting in
the final PFA concentration of 2%. The cells were fixed
for 20 minutes at room temperature, and washed three
times with 50 ml of phosphate-buffered saline (PBS).
Soft agar assays
Soft agar assays were performed in 6-well plates, in assay
medium containing 0.25 g/L glucose (no-glucose DMEM,
Invitrogen, #11966 plus low-glucose DMEM, Invitro-
gen#11885, mixed 3:1), supplemented with 100 mM
sodium pyruvate (Invitrogen, #11360) and 5% FBS. Indivi-
dual wells were coated with 1.5 ml of base medium com-
posed of the aforementioned assay medium mixed with
1% agar (BD, #214230) stock to yield a final concentration
of 0.6% agar. The cells (R2-T1AS, G2B-10A, G-12A,
HuMEC) were harvested with trypsin, resuspended and
mixed in assay medium at various densities and ratios,
according to each experimental design. Volumes of cell
suspensions were adjusted with the assay medium to be
equal for all conditions. In all soft agar cultures, R2-T1AS
cells were plated at a density 1 × 10
4 cells/well. G2B-10A,
G-12A and HuMEC cells were admixed in co-cultures at
densities 1 × 10
4 to 8 × 10
4 cells/well. All cell suspensions
were mixed with the aforementioned assay medium and
1% agar stock, so that the final concentration of agar was
0.3%, and immediately plated on solidified base layers in a
1.5 ml volume. Soft agar cultures were incubated for
21 days and fed with 150 μl of the assay medium twice a
week. The resulting colonies were treated with 200 μl
Nitroblue reagent (1 mg/ml, Amresco, #0329) and incu-
bated at 37°C overnight to develop a blue stain. Colonies
were photographed with a digital camera (Kodak) and the
acquired images were analyzed using the ImageJ software.
Colonies larger than 150 μm in diameter were scored as
positive.
Soft agar assays with conditioned media were con-
ducted using the same protocol as above, except the
assay medium was mixed with the conditioned media at
a 1:1 ratio.
Conditioned media preparation
To generate conditioned media for the soft agar assay,
cells were plated on 10 cm tissue culture plates in 10 ml
of 0.25 g/L glucose, 5% FBS medium (see soft agar
assays). Cell cultures were set up as follows: G2B-10A-
conditioned medium - 6 × 10
6 of G2B cells per plate;
G2B-10A(PFA)-conditioned medium 6 × 10
6 G2B-10A
(PFA) cells per plate. Medium alone (“mock”)w a s
included as a negative control.
To generate conditioned media for clonogenic growth
assay, cells (G2B-10A, G-12A or HuMEC) were plated
in their respective culture media on 10 cm tissue culture
plates at a density of 3 or 6 × 10
6 cells/plate. After over-
night incubation the cells were washed once and media
w e r ec h a n g e dt o1 0m lo f0 . 2 5g / lg l u c o s em e d i an o t
supplemented with FBS. Medium alone (“mock”)w a s
included as a negative control. These media were sup-
plemented with 5% FBS prior to the clonogenicity assay.
To generate conditioned media for analysis by cytokine
antibody array cell cultures were set up in suspension,
on 6-cm plates coated with soft agar base layers (0.25 g/l
glucose, 5% FBS medium containing 0.6% agar). Cells were
suspended in 4 ml of 0.25 g/l glucose, 5% FBS medium
and plated on solidified base layers. Cell cultures were set
up as follows: R2-T1AS-only - 0.3 × 10
6 R2-T1AS cells
per plate, G2B-10A-only - 2.4 × 10
6 of G2B cells per plate,
R2-T1AS/G2B-10A - 0.3 × 10
6 R2-T1AS plus 2.4 × 10
6 of
G2B cells per plate, R2-T1AS/G2B-10A(PFA) - 0.3 × 10
6
R2-T1AS plus 2.4 × 10
6 G2B-10A(PFA) cells per plate.
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were harvested, centrifuged, filtered through 0.45 μm
syringe filter to remove cells and debris, and stored at
4°C or frozen at -80°C, until needed.
Proliferation in suspension assay
The R2-T1AS cells were harvested with trypsin, resus-
pended in 0.25 g/l glucose, 5% FBS medium (see soft agar
assays) and seeded in 6-well, low-attachment plates
(Corning, #3471) at a density of 3 × 10
5 cells/well in 2 ml
volume. Subsequently, an equal volume of conditioned
medium (prepared as for soft agar assays) was added to
the wells. After 24, 48, and 96 hours of incubation cells
were harvested, triturated to dislodge any cell aggregates,
and counted using an automated cell counter (Vi-cell
XR, Coulter). Viability of the cells was determined using
trypan blue exclusion.
Clonogenic growth assay
The R2-T1AS cells were harvested with trypsin, resus-
pended in 0.25 g/l glucose, 5% FBS medium (see soft
agar assays) and plated in 24-well tissue culture plate at
a density 40 cells/well in a 150 μl volume. Subsequently,
an equal volume of conditioned medium, supplemented
with 5% FBS, was added to the wells. The cells were
incubated at 37°C for 5 days, fixed in 2% PFA and
stained with Hoechst dye to visualize the nuclei. Colo-
nies were counted under the fluorescent microscope
and those larger than 10 cells were scored as positive.
Antibody array
The conditioned media were analyzed using cytokine
antibody array (RayBiotech, Human Cytokine Antibody
Array 3) according to manufacturer’s protocol. Briefly,
membranes were blocked for 2 h, afterwards, 1 ml of
conditioned media was added to the membranes and
i n c u b a t e da t4 ° Co v e r n i g h t .D e tection antibody cocktail
was incubated for 0.5 h, followed by HRP-conjugated
streptavidin incubation for 0.5 h. Signal was detected on
an X-ray film using the reagents provided by the manu-
facturer. The arrays were quantified using ImageJ. The
two signals for each cytokine were averaged and nor-
malized to the average of the six positive control signals
on each array.
ELISA
The conditioned media were analyzed using ELISA kits
for the detection of human IL-6 (RayBiotech, #ELH-IL6-
001) and human MCP-1 (RayBiotech, #ELH-MCP1-001).
Briefly, samples of 100 μl of conditioned media were
incubated on ELISA plates at 4°C overnight, followed by
incubations with detection reagents as specified in the
manufacturer’s protocol. Signal was read at 450 nm using
a BioTek Synergy HT plate reader.
Nude mouse xenograft assay
Xenograft experiments were conducted in 7-8 week old
nude female mice, purchased from the NCI. During the
experiment, mice were supplemented with estrogen
released from a subcutaneously placed pellet [29], which
we provided in the event that the injected cells restore
estrogen receptor expression and become estrogen-depen-
dent in vivo. The R2-T1AS and G2B-10A cells were har-
vested by trypsinization and resuspended in PBS at a
density 1 × 10
5 cells/μl. In the R2-T1AS/G2B-10A group,
cells were injected as 1 × 10
6 R2-T1AS cells plus 4 × 10
6
G2B-10A cells per injection (50 μl). In the R2-T1AS/G2B-
10A(PFA) group, cells were injected as 1 × 10
6 R2-T1AS
cells mixed with 4 × 10
6 PFA-fixed G2B-10A cells per
injection (50 μl). In the R2-T1AS-only control, 1 × 10
6
R2-T1AS cells were injected alone (10 μl) and in the G2B-
10A-only control 4 × 10
6 G2B-10A cells were injected
alone (40 μl). Cells were injected bilaterally onto mam-
mary fat pads #4. Tumor size was assessed on a weekly
basis by measurements with an electronic caliper. Volume
was calculated as 0.52 × length × width
2.N u d em o u s e
xenograft experiments were performed under an animal
protocol approved by the Animal Care and Use Commit-
tee of the University of Colorado Denver. Data shown are
combined from 2 independent experiments, with 4 injec-
tions completed for the G2B-10A-only group, 10 injec-
tions for the R2-T1AS-only group, 6 injections for the
R2-T1AS/G2B-10A group, and 10 injections for the
R2-T1AS/G2B-10A(PFA) group.
Tissue processing
Tumors were harvested at day 7 and 14 after inocula-
tion and immediately fixed in 4% PFA in PBS at room
temperature, overnight. Fixed tumors were subsequently
cryopreserved for 24h in 30% sucrose in PBS at 4°C.
Thereafter, tissues were embedded in Tissue-Tek O.C.T.
medium (Sakura, #4583), frozen on dry ice, and stored
at -80°C. For microscopic analysis, frozen tumors were
cut into 10 μm sections and placed on glass slides.
Fluorescence analysis
Sections were thawed at room temperature, washed with
PBS and counterstained with Hoechst dye (Sigma) for 5
min to visualize the nuclei. Slides were mounted using
Fluoromount-G medium (Fisher) and imaged using
fluorescent microscopy. Shown images are composites
of several low-magnification (4×) pictures.
Statistical analyses
Statistical analyses were performed by the University of
Colorado Cancer Center Biostatistics and Bioinformatics
Core. Data were analyzed using linear regression models
for colony numbers and linear mixed models for tumor
volume (mm
3) over time. Least squares means were
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with Dunnett or Tukey-Kramer post-hoc adjustment
methods for multiple comparisons. Tukey’sm e t h o di s
appropriate when all pairwise comparisons are per-
formed at once, while Dunnett’s method is appropriate
for pairwise comparisons between experimental and
control groups only. The family-wise error rate was
fixed at 0.05. Because of the observed skewness in
tumor volume data, we also performed linear mixed
model analyses on the natural log transformed values
(log mm
3) .T h ec o n c l u s i o n sf r o mt h e s ea n a l y s e sw e r e
the same as those using raw tumor volumes. Only the
latter results are presented. The data analyses for this
paper were generated using SAS/STAT software, Ver-
sion 9.2 of the SAS System for Windows. Copyright
©
2002-2008 SAS Institute Inc. SAS and all other SAS
Institute Inc. product or service names are registered
trademarks or trademarks of SAS Institute Inc., Cary,
NC, USA.
Results
Generation of G2B-10A and R2-T1AS cells as models of
benign mammary epithelial cells and breast cancer cells,
respectively
I nt h i ss t u d yw ea d d r e s s e dt h eh y p o t h e s i st h a tb e n i g n
mammary epithelial cells influence the transformed phe-
notype of breast cancer cells. As our primary model of
benign mammary epithelial cells we chose the non-trans-
formed MCF-10A human mammary epithelial cell line.
These cells are spontaneously immortalized, however they
exhibit multiple characteristics of benign mammary
epithelium, such as growth factor-dependent proliferation,
lack of anchorage-independent growth, and lack of tumor-
igenicity in nude mice [30]. In order to track the benign
MCF-10A cells in subsequent studies, we marked them
with green fluorescent protein (GFP) by lentiviral trans-
duction to generate the G2B-10A line. We confirmed that
G2B-10A cells retained their benign phenotype by show-
ing that they maintained the ability to form acini in the 3-
dimensional matrigel assay (not shown), as is typical for
benign mammary epithelial cells [31,32]. As additional
models of benign mammary epithelial cells, we used
HuMEC cells, which are human primary mammary
epithelial cells immortalized by expression of telomerase,
and MCF-12A cells, which we also marked with GFP to
generate the G-12A line [33]. As a model of breast cancer,
we chose MDA-MB-231-T1AS cell line, which is a deriva-
tive of MDA-MB-231 cells, selected for high tumorigeni-
city in mice by in vivo selection [27]. We marked these
cells with red fluorescent protein (DsRed2) by lentiviral
transduction and denoted them R2-T1AS breast cancer
cells.
G2B-10A benign mammary epithelial cells enhance the
anchorage-independent growth of R2-T1AS breast cancer
cells in soft agar
The ability to survive and proliferate without attachment
to substratum is a feature associated with neoplastic trans-
formation. To examine how this anchorage-independent
survival and growth of R2-T1AS breast cancer cells is
modulated by the interactions with benign mammary
epithelial cells, we used the soft agar colony formation
assay. The soft agar assays were carried out for 21 days in
low glucose, 5% serum soft agar medium. We found that
in lower serum concentrations, cancer cells failed to form
colonies in soft agar. Thus, the 5% serum conditions were
optimal to study the effects of benign cells on cancer cells.
To control for the effects of the factors present in serum,
we used medium containing 5% serum in negative control
cultures in all our experiments. First, we verified that the
benign G2B-10A cells do not form colonies in soft agar,
by plating 4 × 10
4 G2B-10A cells alone, and indeed, we
did not detect any colonies in this culture (Figure 1A). To
establish the soft-agar colony number formed by R2-T1AS
cells, we plated 1 × 10
4 R2-T1AS cells alone, which yielded
177 colonies (Figure 1A, red bar). To determine whether
G2B-10A cells influence the R2-T1AS-colony formation,
we co-cultured 1 × 10
4 R2-T1AS cells with G2B-10A cells,
from 1 × 10
4 to 8 × 10
4 cells, resulting in increasing cancer
cell to benign MEC ratios from 1:1 to 1:8. In the co-cul-
ture at a 1:1 ratio, we detected 451 colonies, which repre-
sents a 2.5-fold increase over the R2-T1AS-only culture.
The number of colonies increased with the number of
G2B-10A cells admixed, reaching to 826 for the 1:8 ratio
(Figure 1A, red stippled bars). Thus, the G2B-10A benign
mammary epithelial cells increased the soft-agar colony
formation of R2-T1AS breast cancer cells in a manner
dependent on the number of G2B-10A cells admixed.
Soft agar colonies are composed exclusively of R2-T1AS
cells
To determine whether the benign mammary epithelial
cells contributed to soft agar colonies, we analyzed the
co-cultures using brightfield and fluorescence micro-
scopy. Figure 1B shows brightfield images (Figure 1B
panels i & ii) and the corresponding fluorescent pictures
(Figure 1B, panels iii & iv) of the colonies formed after
a 21-day incubation in the R2-T1AS-only culture (Figure
1B, panels i & iii) and in the R2-T1AS/G2B-10A co-cul-
ture (Figure 1B, panels ii & iv). As expected, all the
colonies visualized in the R2-T1AS-only culture were
composed of red-fluorescent R2-T1AS cells. In the R2-
T1AS/G2B-10A co-culture, we also observed that all
colonies were composed of red-marked R2-T1AS cells.
We did not detect any green-marked G2B-10A cells in
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G2B-10A cells died within 7-10 days (not shown).
G-12A and HuMEC cells increase soft agar growth of
R2-T1AS cells
To investigate whether the ability to enhance R2-T1AS
soft agar colony formation is shared by other benign
mammary epithelial cells, we tested additional benign
cell line models in this assay: G-12A (Figure 2A) and
HuMEC cells (Figure 2B). We determined that G-12A
benign cells did not form colonies in soft agar, while
R2-T1AS cells plated alone formed 65 colonies in this
study (Figure 2A, red bar). In the R2-T1AS/G-12A co-
culture, we detected 987 colonies (Figure 2A, purple
stippled bar), which was equivalent to the number of
colonies counted in a concurrent R2-T1AS/G2B-10A
Figure 1 G2B-10A benign mammary epithelial cells enhance the anchorage-independent growth of R2-T1AS breast cancer cells in soft
agar. (A) Soft agar co-culture of R2-T1AS cells and G2B-10A cells. G2B-10A cells and R2-T1AS were mixed at the indicated ratios and plated in soft agar
cultures in low-glucose, 5% serum media. Colony numbers were scored after 21-day incubation. R2-T1AS cells were plated at a density of 1 × 10
4 cells/
well in each culture (denoted as 1 in the graph labels), and G2B-10A cells were admixed at 1 × 10
4 to 8 × 10
4 cells/well, as indicated (denoted as 1 to
8 in the graph labels). Red bar - R2-T1AS plated alone; red stippled bars - R2-T1AS plated with G2B-10A cells. Graph shows mean number of R2-T1AS
colonies (± standard error) obtained in 4 independent experiments, with each experiment performed in 4 replicate wells. ** p < 0.001 (B) Soft agar
colonies are composed exclusively of R2-T1AS cells. Brightfield (panels i & ii) and fluorescent images (panels iii & iv) of colonies formed after 21-day
incubation. Panels i & iii: The R2-T1AS-only culture; Panels ii & iv: R2-T1AS/G2B-10A co-culture containing exclusively colonies formed by red-marked
R2-T1AS cells (red).
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The result of this study shows that G-12A cells enhance
the formation of colonies by R2-T1AS cells, to an extent
comparable to G2B-10A cells. Upon examination of the
soft agar colonies under fluorescence microscopy, we
found that all colonies in the R2-T1AS/G-12A co-cul-
ture were formed exclusively by R2-T1AS cells as was
the case with R2-T1AS/G-10A co-culture (data not
shown).
Next, we tested the ability of HuMEC cells to increase
the colony formation of R2-T1AS cells (Figure 2B). We
found that HuMEC cells, when plated alone, did not form
colonies in soft agar, while R2-T1AS cells plated alone in
parallel cultures generated 5 colonies (Figure 2B, red bar).
As explained below, the low number of colonies detected
in this study appears to be the result of intrinsic experi-
mental variability. Furthermore, R2-T1AS/HuMEC and
R2-T1AS/G2B-10A co-cultures formed 111 (Figure 2B,
brown stippled bar) and 405 colonies (Figure 2B, red
stippled bar), respectively. This result shows that HuMEC
cells enhanced the colony formation of R2-T1AS cells,
however, their effect was about 4-fold less than that of
G2B-10A cells. We did not examine the R2-T1AS/
HuMEC co-cultures by fluorescence microscopy, since
HuMEC cells were not marked with fluorescent protein,
and could not be visualized by this method. Of note, the
growth of R2-T1AS cells in soft agar fluctuated between
experiments, possibly due to the variations in soft agar
quality and/or conditions. This fluctuation is reflected
by the different colony numbers in R2-T1AS-only cultures
in the three studies shown in Figure 1A (177 colonies),
Figure 2A (65 colonies), and Figure 2B (5 colonies), with
each study consisting of 4 independent experiments and
each of these independent experiments reflecting a mean
of 4 wells. Despite these fluctuations, we observed a con-
sistent increase in the colony formation between the R2-
T1AS-only control and the co-cultures, which reproduced
well within each single experiment (a minimum of a 2.5-
fold increase). None of the benign cell lines ever formed
colonies in soft agar.
Soluble factors secreted by G2B-10A cells increase R2-
T1AS colony formation in soft agar
Since we observed that in the soft agar assay G2B-10A
cells and R2-T1AS cells did not come into physical con-
tact (not shown), we hypothesized that the increased
ability of R2-T1AS cells to form soft agar colonies was
mediated by soluble factors secreted by benign G2B-10A
cells into the semi-solid medium. To test this possibility,
we eliminated the ability of G2B-10A to secrete factors
by fixing them with paraformaldehyde (PFA), and
Figure 2 G-12A and HuMEC benign mammary epithelial cells
enhance the anchorage-independent growth of R2-T1AS breast
cancer cells in soft agar. (A) Soft agar co-culture of R2-T1AS cells and
G-12A cells. R2-T1AS cells were plated alone at a density of 1 × 10
4
cells per well (denoted as 1, red bar), in the R2-T1AS/G-12A co-culture,
1×1 0
4 R2-T1AS were mixed with 8 × 10
4 G-12A cells (denoted as 8,
purple stippled bar), and in the R2-T1AS/G2B-10A co-culture 1 × 10
4
R2-T1AS were mixed with 8 × 10
4 G2B-10A cells (denoted as 8, red
stippled bar). Graph shows mean colony numbers (± standard error)
obtained in 3 independent experiments, with each experiment
performed in 4 replicate wells. (B) Soft agar co-culture of R2-T1AS
cells and HuMEC cells. R2-T1AS cells were plated alone at a density of
1×1 0
4 cells per well (denoted as 1, red bar). In the R2-T1AS/HuMEC
co-culture 1 × 10
4 R2-T1AS cells were mixed with 8 × 10
4 HuMEC cells
(denoted as 8, brown stippled bar), and the R2-T1AS/G2B-10A
co-culture was plated as in Figure 2A (red stippled bar). Graph shows
mean colony numbers (± standard error) obtained in 5 independent
experiments, with each experiment performed in 4 replicate wells.
Different numbers for R2-T1AS-only cultures (65 in Figure 2A, and 5
in Figure 2B) reflect the experimental variability, as detailed in the text.
* p < 0.05, ** p < 0.001, ns - not significant.
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remain intact, but are dead due to cross-linking of inter-
nal proteins, and consequently, they do not secrete any
factors [34]. In this study, R2-T1AS cells formed 61
colonies when plated alone (Figure 3A, red bar) and 341
colonies when mixed with G2B-10A cells (Figure 3A,
r e ds t i p p l e db a r ) .W h e nm i x e dw i t ht h en o n s e c r e t o r y
G2B-10A(PFA) cells, the R2-T1AS cells yielded 83 colo-
nies (Figure 3A, grey stippled bar), which is equivalent
to the number of colonies formed by R2-T1AS alone.
Thus, the increase in the number of colonies formed by
R2-T1AS cells in soft agar was completely abrogated
when G2B-10A cells were fixed with PFA. The results
of this study, reflecting data from 4 independent experi-
ments, with each experiment performed in 4 wells, are
consistent with the idea that G2B-10A benign mammary
epithelial cells support colony-formation of R2-T1AS
breast cancer cells by secretion of soluble factors.
To further explore the hypothesis that soluble factors
secreted by benign mammary epithelial cells mediate the
enhanced colony formation by R2-T1AS cells in soft
agar, we performed assays with conditioned medium
derived from G2B-10A cells. To produce conditioned
medium, G2B-10A cells were incubated in the same
low-glucose, 5% serum medium as in the soft agar
assays. As negative controls, we used medium incubated
without cells (Mock) or medium incubated with G2B-
10A(PFA) cells. In the “mock” medium, R2-T1AS cells
formed 6 colonies (Figure 3B, red bar). This number
increased to 315 for R2-T1AS cells grown in medium
conditioned by G2B-10A cells (Figure 3B, green bar).
However, in medium conditioned by G2B-10A(PFA)
cells only 4 colonies were detected. This result con-
firmed that G2B-10A benign mammary epithelial cells
secrete soluble factors that enhance the colony forma-
tion of R2-T1AS cells in soft agar.
Factors secreted by benign mammary epithelial cells
inhibit the proliferation of R2-T1AS cells in suspension
The fact that factors secreted by G2B-10A cells stimu-
lated formation of colonies in soft agar by R2-T1AS
cells led us to three hypotheses: (1) R2-T1AS cells are
protected from anoikis; (2) the proliferation of R2-T1AS
is enhanced; and/or (3) the clonogenic growth ability of
R2-T1AS is enhanced. To determine whether the factors
secreted by G2B-10A cells modulated the anoikis
response of R2-T1AS cells, we cultured 0.3 × 10
6 R2-
T1AS cells in suspension, in 6-well low-attachment
plates in either mock-conditioned medium, or in med-
ium conditioned by G2B-10A cells, or in medium condi-
tioned by HuMEC cells. After 24h we counted the
numbers of live R2-T1AS cells using the trypan blue
exclusion method (data not shown). We did not detect
any non-viable cells in any of the media conditions.
Figure 3 Increased colony formation in soft agar is mediated
by factors secreted by G2B-10A cells. (A) Paraformaldehyde (PFA)
fixation abrogates the ability of G2B-10A cells to stimulate R2-T1AS
colony formation. As previously, 1 × 10
4 (denoted as 1) R2-T1AS
cells, were plated in soft agar cultures either alone (red bar), or with
8×1 0
4 (denoted 8) live G2B-10A cells (G2B-10A, red stippled bar),
or mixed with 8 × 10
4 (denoted as 8) PFA-fixed G2B-10A cells (G2B-
10A(PFA), grey stippled bar). Data show mean numbers derived
from 4 independent experiments (± standard error), with each
experiment performed in 4 replicate wells. (B) Medium conditioned
by G2B-10A cells enhances colony formation. To produce
conditioned media, G2B-10A cells, or G2B-10A(PFA) cells, or no cells
(mock) were plated in low-glucose, 5%-serum medium, on tissue
culture plates. Conditioned media harvested after a 3-day
incubation were used to set up the soft agar cultures. In all soft
agar cultures, 1 × 10
4 R2-T1AS cells were plated alone (denoted as
1 in the graph labels) in either mock medium (red bar), G2B-10A -
conditioned medium (G2B-10A CM, green bar), or in G2B-10A(PFA) -
conditioned medium (G2B-10A(PFA) CM, grey bar). Data show mean
of 3 independent assays (± standard error), with each assay
performed in 4 replicate wells. **p < 0.001, ns - not significant.
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cally insensitive to anoikis, and the enhanced colony for-
mation observed with admix culture is not due to
protection from anoikis.
We next determined the influence of factors secreted
by benign cells on proliferation of the breast cancer cells.
To this end, we cultured R2-T1AS cells in suspension in
mock, G2B-10A-conditioned, or HuMEC-conditioned
medium, as described above. We counted the numbers of
R2-T1AS cells after 24, 48, and 96 hours of incubation
(Figure 4). In mock-conditioned medium, the number of
R2-T1AS cells increased over the course of the culture,
yielding 0.97 × 10
6 cells per well at 96h (Figure 4, red
line). In conditioned medium derived from G2B-10A
cells we counted 0.64 × 10
6 cells per well (Figure 4, green
line), which constitutes a 34% reduction compared
to mock. In HuMEC-conditioned medium we counted
0.63 × 10
6 cells per well (35% reduction compared to
mock), (Figure 4, brown line). Thus, the growth rate of
R2-T1AS cells in conditioned media derived from both
benign cell lines was slower than in mock-conditioned.
This result, showing that the proliferation of R2-T1AS
cells in suspension culture is inhibited by factors secreted
by the benign epithelial cells, argues that a higher prolif-
eration rate of R2-T1AS cells is unlikely to be the factor
driving the increase in colony number observed in the
soft agar co-cultures.
Factors secreted by benign mammary epithelial cells
stimulate clonogenic growth of R2-T1AS breast cancer
cells
Having determined that protection from anoikis and
higher proliferation rates are unlikely mechanisms
responsible for the increased R2-T1AS colony number
mediated by G2B-10A cells in the soft agar co-cultures,
we proceeded to examine whether factors secreted by
benign mammary epithelial cells stimulated the clono-
genic growth of R2-T1AS cells, using conditioned
media. In contrast to previous experiments, to produce
conditioned media for clonogenicity assays, we cultured
G2B-10A, G-12A and HuMEC cells in low-glucose med-
ium without serum. Both mock and conditioned media
were supplemented with 5% FBS before setting up the
clonogenicity assays. We examined the clonogenic
growth of R2-T1AS cells by plating 40 R2-T1AS cells/
well in a 24-well plate in the conditioned media and
scoring the number of colonies after 5 days of incuba-
tion. As shown in Figure 5, R2-T1AS cells formed 12
colonies in mock medium, 19 colonies in G2B-10A con-
ditioned medium (58% increase compared to mock), 18
colonies in G-12A conditioned medium (50% increase),
and 23 colonies in HuMEC-conditioned medium (92%
increase). These data, derived from 8-15 independent
experiments, with each of these experiments performed
in 4 wells, demonstrate that the factors secreted by
benign mammary epithelial cells stimulate clonogenic
growth of R2-T1AS cells.
G2B-10A conditioned medium contains several cytokines
and specifically includes MCP-1
To identify factors selectively secreted by G2B-10A or R2-
T1AS cells, we screened conditioned medium derived
from both cell cultures, using a cytokine antibody array.
The R2-T1AS cells were plated at 8 times lower cell num-
ber, to reflect the 1:8 (R2-T1AS/G2B-10A) ratio, at which
they were co-cultured compared to G2B-10A cells in the
soft agar assay. This way, by comparing factors secreted by
G2B-10A versus R2-T1AS cells alone, we were able to
establish whether any factors represented on the array
were specifically secreted by one cell type or the other. To
produce the conditioned media, G2B-10A and R2-T1AS
Figure 4 Factors secreted by benign mammary epithelial cells
inhibit the proliferation of R2-T1AS in suspension. Graph shows
proliferation of R2-T1AS cells in suspension cultures in mock-
conditioned medium (red line), G2B-10A - conditioned medium
(G2B-10A CM, green line), or HuMEC - conditioned medium (HuMEC
CM, brown line). To produce conditioned media, G2B-10A cells,
HuMEC cells, or no cells (mock) were plated in low-glucose, 5%
serum medium, on tissue culture plates. Conditioned media were
harvested after a 3-day incubation. For suspension culture, R2-T1AS
cells were seeded in conditioned media, in 6-well, low-attachment
plates, at a density of 0.3 × 10
6 cells per well. After 24, 48, and 96
hours media with cells were harvested and cell numbers were
determined using an automated cell counter (ViCell), with the use
of trypan blue exclusion. Each data point represents a mean of 3
independent experiments (± standard error), with each experiment
performed in 3 replicate wells. ** p < 0.001 - for 96 hours time
point.
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serum medium. The cytokine antibody arrays (Figures 6A
&6B), which we quantified by densitometry (Figure 6C),
show that a strong MCP-1 signal and a weak IL-1a signal
were detected specifically in the G2B-10A-conditioned
medium (Figure 6A). We also detected a weak ENA-76
signal specific to G2B-10A conditioned medium (Figure
6A), however this signal was not reproducible. Further-
more, the GRO-a signal was increased 6-fold and the IL-
10 signal was increased 2-fold in the G2B-10A-condi-
tioned medium, compared to the R2-T1AS-conditioned
medium. In the repeat assay, we also detected increased
GRO signal in G2B-10A conditioned medium compared
to R2-T1AS medium. However, the GRO-a signals were
equal in the study shown in Figures 6A and 6B. In the R2-
T1AS media, we detected IL-6 and GM-CSF signals that
were weakly detectable on the G2B-10A array (Figure 6A
and 6B). Both media generatede q u a ls i g n a l sf o rI L - 8 .
Furthermore, the analysis of mock-conditioned medium
did not produce any strong signals (not shown). Two cyto-
kines previously shown to mediate interactions between
mesenchymal cells and cancer cells, SDF-1 and CCL5/
RANTES, were represented on the array and did not pro-
duce detectable signals. To verify the cytokine array data,
we performed an ELISA analysis of conditioned media
(Figure 6D), focusing on MCP-1, which was a high-abun-
dance cytokine specific to G2B-10A medium. This ELISA
analysis showed that G2B-10A medium contained 391 pg/
ml MCP-1, while in R2-T1AS medium MCP-1 was unde-
tectable, which validates the array data.
G2B-10A benign mammary epithelial cells increase the
tumorigenicity of R2-T1AS cells in vivo independent of
factors secreted by benign cells
The studies included thus far address the role of benign
mammary epithelial cells in enhancing the in vitro
Figure 5 Factors secreted by benign mammary epithelial cells stimulate clonogenic growth of R2-T1AS breast cancer cells. Graph shows 24-
well clonogenic growth assay of R2-T1AS cells in mock-conditioned medium (red bar), or in conditioned media derived from G2B-10A cells (G2B-10A
CM, green bar), or G-12A cells (G-12A CM, purple bar), or HuMEC cells (HuMEC CM, brown bar). To produce conditioned media, G2B-10A, G-12A, and
HuMEC cells, or no cells (mock) were cultured in serum-free, low-glucose medium for 3 days. Conditioned media were supplemented with 5% FBS at
the time of the plating of R2-T1AS cells for the clonogenic growth assay. R2-T1AS cells were plated at a density of 40 cells/well in a 24-well plate, in
conditioned media, as indicated. Colonies of 10 cells or more were counted after 5 days. Data represent mean number derived from 8 to 15
independent assays (denoted as “n” in graph labels), with each assay performed in 4 replicate wells. **p < 0.001, *p < 0.05, ns-not significant.
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determine whether benign mammary epithelial cells also
influence the phenotype of breast cancer cells in vivo,w e
examined the effects of G2B-10A cells on the tumorigeni-
city of R2-T1AS cells in a nude mouse xenograft model.
First, we injected 4 × 10
6 G2B-10A cells alone to verify
that these cells were not tumorigenic, and indeed, G2B-
10A cells did not form any tumors (Figure 7, green line).
To establish the ability of R2-T1AS cells to form tumors
in mice, we injected 1 × 10
6 R2-T1AS cells alone, which
formed tumors that on average measured 545 mm
3 in
volume on day 28 after inoculation (Figure 7, red line). To
determine whether G2B-10A cells influenced the tumori-
genicity of R2-T1AS breast cancer cells, we co-injected
4×1 0
6 G2B-10A cells with1 × 10
6 R2-T1AS cells, main-
taining the increased ratio of benign to malignant cells, as
used in the in vitro studies. As expected from in vitro
r e s u l t s ,t h ev o l u m eo ft h e s eR 2 - T 1 A S / G 2 B - 1 0 Am i x e d
tumors reached 1521 mm
3 on day 28, which is about
3-fold larger than R2-T1AS-only tumors (Figure 7, blue
line). The data described here are derived from 2 separate
experiments. We also performed 3 additional separate
experiments (not shown), which yielded similar results.
The result shown in Figure 7 recapitulated the in vitro stu-
dies, in which the G2B-10A cells enhanced the trans-
formed phenotype of R2-T1AS. Next, we tested the
hypothesis that the enhanced tumorigenicity of R2-T1AS
in vivo is mediated by soluble factors secreted by G2B-
10A cells, as the in vitro d a t as u g g e s t( F i g u r e3 ) .T ot h i s
end, we co-injected 1 × 10
6 R2-T1AS cells with 4 × 10
6
paraformaldehyde-fixed G2B-10A(PFA) cells. Unexpect-
edly, fixation of G2B-10A cells with PFA failed to reduce
Figure 6 Analysis of G2B-10A and R2-T1AS conditioned media. (A) Cytokine antibody array analysis of medium conditioned by G2B-10A cells,
plated at a density of 1.5 × 10
6 cells/ml. (B) Cytokine antibody array analysis of medium conditioned by R2-T1AS cells, plated at a density of 1.875 ×
10
5 cells/ml. The R2-T1AS cells were plated at 8 times lower density to reflect the 1:8 ratio at which cancer and benign cells were co-cultured in the
soft agar assays. Cells were cultured in suspension, in low-glucose, 5% serum medium. Conditioned media were harvested after 3 days of
incubation and analyzed by cytokine antibody array. Both membranes were incubated with 1 ml of conditioned media derived from the indicated
cell lines, underwent the same treatment and were exposed to the X-ray film for the same time. POS - positive control spots, solid lines - cytokines
expressed differentially in the two cultures, dashed lines - not reproducible signals. (C) Quantification of the arrays in Figures 6A and 6B. The signals
on the G2B-10A array (green bars) and R2-T1AS array (red bars) were quantified by densitometry and normalized to the average of positive control
signals (POS). (D) Analysis of MCP-1 concentration in media conditioned by R2-T1AS cells or G2B-10A cells (green bar) by ELISA. nd - not detectable.
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G2B-10A(PFA) grafts reached 1813 mm
3, which is equiva-
lent to the R2-T1AS/G2B-10A mixed tumors. While this
result is not fully consistent with what we observed in
vitro, the complexity of the in vivo intact mammary gland
may require several influences (secreted factors, direct cell
contact, stromal contributions, etc) to promote optimal
growth of R2-T1AS tumors in the nude mouse xenograft
model.
To determine whether G2B-10A cells contribute to
tumor masses, we harvested tumors from R2-T1AS/
G2B-10A and R2-T1AS groups at 7 and 14 days post-
inoculation and we also harvested tumors from all 3
groups (R2-T1AS/G2B-10A, R2-T1AS/G2B-10A(PFA)
and R2-T1AS) at 28 days post-inoculation. Tumor sec-
tions were analyzed by fluorescence microscopy. As
shown in Figure 8A, in the R2-T1AS-only group, the
tumors 7 days post-injection were composed of solid tis-
sue (arrowhead), and of necrotic areas of disaggregated
cells and debris (asterisk). In the R2-T1AS/G2B-10A
mixed group, 8 out of 10 tumors analyzed formed a cyst
at 7 days, with the lumen filled with cellular debris and
fluid, surrounded by green-marked G2B-10A cells and
red-marked R2-T1AS cells. As shown in Figure 8B, at
day 14 post-injection, the R2-T1AS/G2B-10A mixed
t u m o r sh a df i l l e dt h ec y s ta n dd e v e l o p e das o l i ds t r u c -
ture, resulting in tumors larger than the R2-T1AS-only
tumors. However, the benign G2B-10A cells were no
longer detectable at 14 days. Similarly, at 28 days post-
inoculation, tumors from all groups (R2-T1AS, R2-
T1AS/G2B-10A and R2-T1AS/G2B-10A(PFA)) were
composed solely of R2-T1AS cells forming solid masses,
with tumors arising from R2-T1AS/G2B-10A injections
and R2-T1AS/G2B-10A(PFA) injections showing no dif-
ferences (see Additional file 1). This analysis reveals that
G2B-10A benign cells disappeared from the tumor tis-
sue within 2 weeks after inoculation. Nonetheless, the
early and transient presence of G2B-10A (± PFA) cells
resulted in higher tumorigenicity of R2-T1AS cells.


















Figure 8 Morphology and cellular composition of tumors
harvested at day 7 and day 14. (A) Fluorescent sections of tumors
harvested at 7 days post-inoculation (red fluorescence - R2-T1AS cells;
green fluorescence - G2B-10A cells). Left panel: R2-T1AS - tumors
resulting from the injection of R2-T1AS cells alone, partially composed
of solid tissue (arrowhead) and partially of necrotic areas (asterisk).
Right panel: R2-T1AS/G2B-10A - tumors resulting from the injection of
R2-T1AS cells mixed with G2B-10A. Majority (8 of 10) of tumors at day
7 had cystic structure. The lumen of the cyst (L) was filled with fluid
and cellular debris, and surrounded by G2B-10A (green fluorescence)
and R2-T1AS (red fluorescence) cells. (B) Fluorescent sections of tumors
harvested at 14 days post-inoculation (red fluorescence - R2-T1AS cells;
green fluorescence - G2B-10A cells). Both R2-T1AS and R2-T1AS/G2B-
10A mixed tumors were composed of solid tissue formed by R2-T1AS
cells (red fluorescence). Scale bars: 1 mm.
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R2-T1AS cells to secrete soluble factors
To explain the divergence between the in vitro result,
where the enhanced clonogenicity of R2-T1AS breast
cancer cells was mediated by factors secreted by the
benign cells, and the in vivo result, where G2B-10A
benign cells increased the tumorigenicity of R2-T1AS
independent of secreted factors, we reasoned that G2B-
10A cells may enhance the tumorigenic growth of R2-
T1AS cells through direct cell-cell contact, whereby
physical contact between R2-T1AS cells and G2B-10A
cells (either live, or PFA-fixed) would induce secretion
of auto-stimulatory factors by R2-T1AS cells. Such cell-
cell contact occurs between R2-T1AS and G2B-10A
cells (or R2-T1AS and G2B-10A(PFA cells)), when
mixed cells are injected into mice, but not in the soft
agar assays. We addressed this hypothesis indirectly, by
using cytokine antibody arrays and ELISA assays to ana-
lyze conditioned media from the R2-T1AS/G2B-10A
and the R2-T1AS/G2B-10A(PFA) co-cultures, in which
cells were plated in suspension at a high density, thus
allowing them to aggregate and form direct cell-cell
contacts (Figures 9A &9B). The conditioned media from
these high-density co-cultures were compared to condi-
tioned media derived from either R2-T1AS or G2B-10A
cells cultured alone (Figures 9C &9D) and the arrays
were quantified by densitometry (Figure 9E). Both R2-
T1AS/G2B-10A and R2-T1AS/G2B-10(PFA) co-cultures
generated several cytokine signals that were specifically
increased compared to R2-T1AS and G2B-10A mono-
cultures (Figures 9A &9B). That is, both co-cultures
generated a strong IL-6 signal that was increased about
5-fold compared to R2-T1AS alone and weakly detect-
able in G2B-10A mono-culture. Additionally, both co-
cultures also generated a GM-CSF signal that was
increased about 10-fold compared to R2-T1AS alone
and undetectable in G2B-10A conditioned medium.
Also, both co-cultures generated a weak IL-7 signal,
which was not generated by G2B-10A or R2-T1AS cells
alone. Furthermore, R2-T1AS/G2B-10A and R2-T1AS/
G2B-10(PFA) co-cultures generated signals that were
selectively increased in both co-cultures compared to
R2-T1AS mono-culture (GRO, GRO-a,I L - 1 a,I L - 8a n d
IL-10), but these factors were also secreted by G2B-10A
cells cultured alone. EGF was detected in all cultures,
but this signal was not reproducible. To confirm the
array data, we performed ELISA analysis focusing on IL-
6, which was the cytokine that generated a strong signal
specific to the co-cultures (Figures 9A, B, C, D and 9E).
The ELISA data showed that the G2B-10A and R2-
T1AS mono-cultures contained 19 pg/ml and 54 pg/ml
of IL-6, respectively (Figure 9F). Whereas the R2-T1AS/
G2B-10A co-culture contained 624 pg/ml IL-6 (12-fold
increase over R2-T1AS mono-culture) and the R2-
T1AS/G2B-10A(PFA) co-culture contained 878 pg/ml
IL-6 (16-fold increase). Analysis of separately prepared
conditioned media revealed a similar 4-10-fold increase
of IL-6 concentration in R2-T1AS/G2B-10A and R2-
T1AS/G2B-10A(PFA) co-cultures compared to the R2-
T1AS mono-culture (data not shown). Thus, the strong
IL-6 and GM-CSF signals are unique to the co-cultures.
Since PFA-fixed cells do not produce active secretions
(Figure 3), this result identifies the R2-T1AS cells as the
cell type that was induced to secrete IL-6 and GM-CSF
cytokines in both co-cultures with G2B-10A (±PFA)
cells. This experiment suggests that physical contact
between R2-T1AS cells and either live or PFA-fixed
G2B-10A cells, resulting in induction of auto-stimula-
tory cytokines by R2-T1AS cells, is a plausible mechan-
ism responsible for increased tumorigenicity of R2-
T1AS cells in vivo.
Discussion
Previous research on the role of the microenvironment
in cancer has primarily focused on the interactions
between cancer cells and stromal cell populations, rather
than interactions between cancer cells and benign
epithelial cells. Given that, in breast cancer, the earliest
stage tumor cells interact with mammary epithelial cells,
and not stromal cells, we used in vitro and in vivo
approaches to show that several cell line models of
benign mammary epithelial cells promote the trans-
formed phenotype of R2-T1AS breast cancer cells.
While the in vitro studies established that factors
secreted into the media by G2B-10A cells are required
for the enhanced clonogenic behavior of R2-T1AS cells,
to our surprise, we found that PFA-treated, metaboli-
cally inert G2B-10A cells were able to increase tumor
growth in vivo as efficiently as non-PFA-treated G2B-
10A cells. This result prompted us to determine that
P F A - t r e a t e dG 2 B - 1 0 Ac e l l sw e r ea b l et oe n g a g eR 2 -
T1AS cells by direct cell-cell contact and cause them to
secrete growth factors, such as IL-6 and GM-CSF. In
sum, these data are significant because they provide a
paradigm shift in our understanding of the role of
benign mammary epithelial cells during the course of
breast cancer development. Benign MECs are not simply
a passive, noncontributory component of the tumor
microenvironment, but rather our data highlight that
they play a direct role in enhancing the tumorigenic
phenotype of breast cancer cells.
In the few previous studies analyzing the effects of
benign epithelial cells on the transformed phenotype of
distinct cancer cell types, investigators have reported
both stimulatory and inhibitory effects [21-26]. With
regards to motility and invasion, several studies reported
that benign epithelial cells increased the in vitro motility
and invasion of cancer cells, with breast cancer cell
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Page 13 of 17Figure 9 Both live and PFA-fixed benign G2B-10A cells stimulate R2-T1AS cells to secrete soluble factors. (A-D) Cytokine antibody array
analyses of conditioned media derived from: (A) R2-T1AS/G2B-10A co-culture (1.875 × 10
5 R2-T1AS cells/ml mixed with 1.5 × 10
6 G2B-10A cells/
ml), (B) R2-T1AS/G2B-10A(PFA) co-culture (1.875 × 10
5 R2-T1AS cells/ml mixed with 1.5 × 10
6 PFA-fixed G2B-10A cells/ml), (C) R2-T1AS alone
(1.875 × 10
5 R2-T1AS cells/ml). The R2-T1AS cells were plated at 8 times lower density than G2B-10A cells to reflect the 1:8 ratio at which cancer
and benign cells were co-cultured in the soft agar assays. (D) G2B-10A alone (1.5 × 10
6 cells/ml). To produce conditioned media, cells were
cultured in suspension, in low-glucose, 5% serum conditions and conditioned media were harvested after 3 days of incubation. All antibody
array membranes were incubated with 1 ml of conditioned media from the indicated cultures. All membranes underwent the same treatment
and were exposed to the X-ray film for the same time. Membranes shown were generated in a different experiment than the membranes in
Figure 6. POS - positive control spots, black solid lines - differentially expressed cytokines, red lines - signals specific to co-cultures, dashed black
lines - not reproducible signals. (E) Quantification of the arrays in Figures 9A, 9B, 9C, and 9D. The signals on the R2-T1AS array (red bars), G2B-
10A array (green bars), R2-T1AS/G2B-10A array (blue bars) and R2-T1AS/G2B-10A(PFA) array (gray bars) and were quantified by densitometry and
normalized to the average of positive control signals (POS). (F) ELISA analysis of IL-6 concentration in the conditioned media from the following
cultures: R2-T1AS (red bars), G2B-10A (green bars), R2-T1AS/G2B-10A (blue bars) and R2-T1AS/G2B-10A(PFA) (gray bars).
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epithelial cells [21,24]. In contrast, with regards to cell
proliferation, it has been reported that conditioned
media derived from benign mammary epithelial cells
suppressed proliferation of a variety of breast cancer cell
lines in monolayer cultures, in three-dimensional matri-
gel cultures, in cultures on collagen, and also in soft
agar assays [22,23,25,26]. Cumulatively, these studies
suggest an inhibitory effect of benign mammary epithe-
lial cells on the proliferation of tumor cells. However,
these studies did not address the effects of benign cells
on the clonogenicity in vitro or tumorigenicity in vivo of
breast cancer cells.
Our work concentrated specifically on the ability of
G2B-10A, G-12A and HuMEC benign cells to enhance
R2-T1AS colony formation when cultured at clonogenic
(single-cell) density in vitro and the ability of G2B-10A
cells to enhance R2-T1AS tumor formation in vivo,a n d
we consistently found a promotional effect of the benign
MECs on these aspects of the transformed phenotype of
R2-T1AS breast cancer cells. The relative strength of
the effects of the three benign cell lines on the R2-T1AS
cells varied between the soft agar and the clonogenicity
assays. These differences likely stem from the fact that
these assays test for different properties of R2-T1AS
cells. Furthermore, under our experimental conditions,
HuMEC cells died sooner than G2B-10A or G-12A cells
and thus the exposure of R2-T1AS cells to HuMEC
cells in the co-cultures was shorter than exposure to the
remaining two benign cell lines. Nevertheless, our prolif-
eration data (Figure 4) are consistent with previous
reports demonstrating an anti-proliferative effect of
benign cells on malignant cells. This anti-proliferative
effect of benign cells suggests that the increased R2-
T1AS colony numbers and enhanced tumor growth that
we observe in response to G2B-10A cells are unlikely to
be due to increased R2-T1AS cellular proliferation. In
this regard, the results of the clonogenicity assays pro-
vided important mechanistic insights. Specifically, we
used low-glucose and 5%-serum conditions, such that in
these conditions R2-T1AS breast cancer cells exhibited
limited capacity for clonogenic growth. However, condi-
tioned media derived from benign mammary cell lines
all enhanced R2-T1AS colony numbers 5-days after
p l a t i n g( F i g u r e5 ) ,a n ds i n c ew eo b s e r v e dm o r eR 2 -
T1AS colonies with media from benign cells, rather
than larger colonies, these data suggest that the key
effect is via initial survival. Furthermore, both in soft
agar co-cultures and in xenograft assays, the benign
cells died early, suggesting again, that their effect is on
the initial survival of R2-T1AS cells.
In order to better define the clonogenicity-enhancing
activity contributed by benign MECs, we used several
in vitro approaches and found consistent results showing
that G2B-10A cells secrete factor(s) that promote
clonogenicity, and that G2B-10A cells do not need to
interact with R2-T1AS cells to secrete these factors. Simi-
lar in vitro studies, employing conditioned media derived
from stromal cells, have shown that stromal cells secrete
SDF-1 and CCL5, which promote cancer cell proliferation
and invasion [12,14,15]. Our array analysis revealed that
MCP-1 and IL-1a were secreted by benign G2B-10A cells,
but not by malignant R2-T1AS cells, and GRO-a signal
was increased in G2B-10A conditioned medium. Of note,
both SDF-1 and CCL5 were present on the array, but we
failed to detect these two factors in conditioned media
derived from either the G2B-10A or R2-T1AS cells. While
we have not yet identified the G2B-10A-derived factor
contributing to the in vitro effects, we proved that secreted
factors are key effectors in vitro, by treating G2B-10A cells
with PFA, which consistently induced the loss of colony
formation-enhancing activity contributed by benign MECs
in soft agar (Figure 3B). However, the fact that PFA-trea-
ted G2B-10A cells promoted equivalent tumor growth as
untreated G2B-10A cells in vivo, revealed that factors
secreted by G2B-10A cells were not required in the in vivo
assay, and that more complex mechanisms were likely. For
example, the in vivo xenograft assay tests for several com-
plex features of cancer cells, such as survival in hypoxic
conditions, survival in nutrient-deprived conditions, and
the ability to establish a vascular network, none of which
are factors in the in vitro assays.
We propose that benign mammary epithelial cells
enhance the tumorigenicity of breast cancer cells in vivo
by engaging them in direct cell-cell contact between
these two cell types, leading to secretion of soluble fac-
tors by R2-T1AS that enhance their tumorigenicity. This
concept is supported by the results of the high-density
co-culture, which allowed direct cell-cell contacts
between benign and malignant cells, and showed that
G2B-10A cells ± PFA induce a significant increase in
secretion of IL-6 and GM-CSF in R2-T1AS cells (Figure
9). A similar effect, whereby direct cell-cell contact
between breast cancer cells and mesenchymal stem cells
induced secretion of CCL5 by the latter cells has been
reported previously [14]. Also, direct contact between
cancer cells and serum-activated fibroblasts has been
found to stimulate the clonogenic growth of the former
[35]. Notably, a recent publication implicated IL-6 as a
critical regulator of tumor stem cell renewal, by showing
that IL-6 treatment promoted growth of mammospheres
formed by MCF-7 cells and primary breast cancer cells
[36]. Furthermore, IL-6 and its downstream signaling
pathway have been implicated in the regulation of pro-
liferation, survival, and metabolism of cancer cells
[37,38]. Finally, normal mammary epithelial cells have
been shown to be essential for maintaining and directing
the activity of mammary stem/progenitor cells in
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together, these data imply that cell-cell contact between
nontransformed G2B-10A cells and malignant R2-T1AS
cells promotes secretion of IL-6 by R2-T1AS breast can-
cer cells, and that IL-6 is a good candidate to mediate
enhanced tumorigenicity of R2-T1AS cells, possibly by
inducing tumor stem cell survival.
While our data support the hypothesis that benign
MECs increase the tumorigenicity of breast cancer cells
by engaging them in direct cell-cell contact leading to
secretion of soluble autocrine factors by R2-T1AS, the
promotional effects of benign MECs may be explained
by several mechanisms. The most obvious possibility is
that benign cells increase the tumorigenicity of R2-
T1AS via immune cells recruited to the tumor site by
G2B-10A cells ± PFA. However, we were unable to
establish that immune infiltrates were increased when
R2-T1AS cells were injected with the benign cells com-
pared to R2-T1AS cells alone (data not shown). Another
possibility is that co-injected benign cells serve as a
nutrient source for the breast cancer cells, thus increas-
ing their tumorigenic growth. Indeed, although phagocy-
tosis is not the primary function of mammary epithelial
cells, they may in fact phagocytize other cells [42,43].
Another possibility is that the benign cells provide a
structural or scaffolding support, whereby the cystic
structure observed in tumors 7 days post-injection pro-
vides a scaffold that influences oxygenation and/or
nutrient availability, which then facilitates tumorigenic
growth. However, previously published tumor xenograft
studies in nude mice revealed that interactions between
cancer cells and activated stromal cells resulted in larger
tumors, compared to cancer cells plus normal nonacti-
vated stromal cells, and that this response was mediated
by paracrine factors, thus minimizing the contribution
of scaffolding effects [13,14]. Finally, we recognize that
the PFA-fixed cells may elicit specific, PFA-dependent
effects that are separate from those elicited by live G2B-
10A cells. Thus, the possibility remains that in mixed
R2-T1AS/G2B-10A xenografts, the increased tumori-
genicity is in fact dependent on the factors secreted by
benign cells, whereas in R2-T1AS/G2B-10A(PFA) xeno-
grafts, the effect is dependent on a different, unknown
mechanism.
Conclusions
The critical contribution of this work is that benign MECs
directly enhance the clonogenicity and tumorigenicity of
breast cancer cells. This is an important and clinically rele-
vant new observation that may play a critical role in the
very early stages of cancer development, when a few can-
cer cells are surrounded by an excess number of adjacent
benign epithelial cells. Thus, these results expand our
understanding of the tumor microenvironment to include
the benign epithelial cell compartment as a relevant con-
tributor to tumor progression.
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